GIVLAARI Trademark

Trademark Overview


On Thursday, December 20, 2018, a trademark application was filed for GIVLAARI with the United States Patent and Trademark Office. The USPTO has given the GIVLAARI trademark a serial number of 88237293. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The GIVLAARI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of porphyria
givlaari

General Information


Serial Number88237293
Word MarkGIVLAARI
Filing DateThursday, December 20, 2018
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6164815
Registration DateTuesday, September 29, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements


Description of MarkThe mark consists of the word "GIVLAARI" and a design of four curved, nested bands.
Goods and ServicesPharmaceutical preparations for the treatment of porphyria
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "GIVLAARI" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 12, 2019
Primary Code005
First Use Anywhere DateTuesday, December 10, 2019
First Use In Commerce DateTuesday, December 10, 2019

Trademark Owner History


Party NameAlnylam Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Friday, March 15, 2019ASSIGNED TO EXAMINER
Monday, December 24, 2018NEW APPLICATION ENTERED
Saturday, January 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 15, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 11, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, February 5, 2020SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 11, 2019USE AMENDMENT FILED
Wednesday, December 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 18, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 5, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 29, 2020ASSIGNED TO EXAMINER
Sunday, June 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, June 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, August 1, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 20, 2020ASSIGNED TO LIE
Monday, August 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 28, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER